Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jan 27, 2024; 16(1): 103-112
Published online Jan 27, 2024. doi: 10.4240/wjgs.v16.i1.103
Published online Jan 27, 2024. doi: 10.4240/wjgs.v16.i1.103
Risk factors for recurrence of common bile duct stones after surgical treatment and effect of ursodeoxycholic acid intervention
Wei-Hong Yuan, Zheng Zhang, Qi Pan, Bo-Neng Mao, Tao Yuan, Department of Gastroenterology, Yixing People’s Hospital, Yixing 214200, Jiangsu Province, China
Author contributions: Yuan WH designed and wrote the paper; Yuan T designed the research and supervised the report; Zhang Z, Pan Q and Mao BN designed the research and contributed to the analysis; all authors have approved the manuscript.
Institutional review board statement: The study was reviewed and approved by the Institutional Review Board of Yixing People’s Hospital.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: The authors declare no conflict of interest.
Data sharing statement: The clinical data used in this study can be obtained from the corresponding author upon request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tao Yuan, MM, Attending Doctor, Department of Gastroenterology, Yixing People’s Hospital, No. 1588 Xincheng Road, Yixing 214200, Jiangsu Province, China. staff1848@yxph.com
Received: November 3, 2023
Peer-review started: November 3, 2023
First decision: November 16, 2023
Revised: November 29, 2023
Accepted: January 2, 2024
Article in press: January 2, 2024
Published online: January 27, 2024
Peer-review started: November 3, 2023
First decision: November 16, 2023
Revised: November 29, 2023
Accepted: January 2, 2024
Article in press: January 2, 2024
Published online: January 27, 2024
Core Tip
Core Tip: Choledocholithiasis is a common biliary disorder that can be treated by endoscopic retrograde cholangiopancreatography. However, postoperative recurrence of bile duct stones is a common complication. Ursodeoxycholic acid (UDCA) is used to treat biliary disorders mainly by lowering cholesterol saturation, facilitating bile flow, and reducing inflammation. Through these actions, UDCA improves symptoms, prevents and treats gallstone formation, and promotes biliary health in patients with biliary tract disorders.